Comparison between Jindal Poly Films FPO and Nectar Lifesciences IPO.
Jindal Poly Films FPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Nectar Lifesciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Jindal Poly Films FPO | Nectar Lifesciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | FPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | JM Morgan Stanley Pvt.Ltd. ICICI Securities Ltd. | ICICI Securities Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Jindal Poly Films FPO is up to ₹300.00 Cr whereas the issue size of the Nectar Lifesciences IPO is up to ₹92.88 Cr. The final issue price of Jindal Poly Films FPO is ₹360.00 per share and of Nectar Lifesciences IPO is ₹240.00 per share.
| Jindal Poly Films FPO | Nectar Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | ₹200.00 per share |
| Issue Price (Upper) | ₹400.00 per share | ₹240.00 per share |
| Issue Price (Final) | ₹360.00 per share | ₹240.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 83,33,325 shares | 38,70,000 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹92.88 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 83,33,325 shares | 38,70,000 shares |
| Issue Size Total (Amount) | up to ₹300.00 Cr | up to ₹92.88 Cr |
Jindal Poly Films FPO opens on Jun 09, 2005, while Nectar Lifesciences IPO opens on Jun 22, 2005. The closing date of Jindal Poly Films FPO and Nectar Lifesciences IPO is Jun 15, 2005, and Jun 28, 2005, respectively.
Jindal Poly Films FPO P/E ratio is , as compared to Nectar Lifesciences IPO P/E ratio of .
| Jindal Poly Films FPO | Nectar Lifesciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.48 | 89.08 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 55.2 | 65.93 | ||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.28 | 31.3 | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Jindal Poly Films FPO Retail Individual Investors (RII) are offered 29,16,665 shares while in Nectar Lifesciences IPO retail investors are offered 29,16,665 shares. Qualified Institutional Buyers (QIB) are offered 41,66,662 shares in Jindal Poly Films FPO and 19,35,000 shares in Nectar Lifesciences IPO.
| Jindal Poly Films FPO | Nectar Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 41,66,662 shares | 19,35,000 shares |
| NII | 12,49,998 shares | 5,80,500 shares |
| RII | 29,16,665 shares | 13,54,500 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 83,33,325 shares | 38,70,000 shares |
Jindal Poly Films FPO subscribed in total, whereas Nectar Lifesciences IPO subscribed .
